Registration for ‘5 Slides: The policy implications of new medicines’ is now open!


Nicole Pasia


The question of increasing affordable access to care has risen to the forefront of health policy conversations in the wake of COVID-19—a shift from previously cost-focused models. In the world of pharmacy, health leaders are engaging in conversations about navigating cost pressures as Florida continues to navigate the pandemic. State of Reform looks forward to diving into this topic at our upcoming “5 Slides: The policy implications of new medicines” virtual convening. The conversation will take place February 8, from 12:00—1:00pm ET. 

In this discussion, health experts will share their thoughts on the path to making pharmaceutical care more affordable by way of formulary adjustments, increasing the use of biosimilars, or other innovative solutions.


Stay one step ahead. Join our email list for the latest news.



The conversation will bring together Karen van Caulil, Ph.D., President & Chief Executive Officer, Florida Alliance for Healthcare Value, Omar Rashid, M.D., Surgical Oncologist, Holy Cross Health, and Wayne Winegarden, Ph.D., Senior Fellow and Director, Center for Medical Economics and Innovation, Pacific Research Institute

Each panelist will bring with them a slide that highlights a question or topic they feel is key to the conversation. The event is free to attend, but make sure to register to join. You’ll have the ability to pose questions and participate in the conversation, just as you can at our conferences.